Active ingredient
Atracurium
6 finished FDA listings contain Atracurium as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- ATRACURIUM BESYLATE
- Dosage forms
- Injection, Solution
- Routes
- Intravenous
- Manufacturers / labelers
- 3
- Strengths listed
- 10 mg/ml · 100 mg/10ml · 50 mg/5ml
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1218
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| ANDA 091488 | MEITHEAL | 2012-02-17 | 1 |
| ANDA 091489 | MEITHEAL | 2012-02-17 | 1 |
| ANDA 090761 | HOSPIRA INC | 2012-10-18 | 1 |
| ANDA 090782 | HOSPIRA INC | 2012-10-18 | 1 |
| ANDA 206010 | EUGIA PHARMA | 2015-04-08 | 1 |
| ANDA 206011 | EUGIA PHARMA | 2015-04-08 | 1 |
Official labeling on DailyMed
- ATRACURIUM BESYLATE INJECTION, SOLUTION [MEITHEAL PHARMACEUTICALS INC.] · version 5 · 2024-12-06
- ATRACURIUM BESYLATE INJECTION, SOLUTION [HOSPIRA, INC.] · version 12 · 2023-11-27
- ATRACURIUM BESYLATE INJECTION, SOLUTION [AUROMEDICS PHARMA LLC] · version 5 · 2022-05-31
- ATRACURIUM BESYLATE INJECTION, SOLUTION [AUROMEDICS PHARMA LLC] · version 5 · 2022-02-15
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.